CHIMERIX INC. news, videos and press releases
For more news please use our advanced search feature.
CHIMERIX INC. - More news...
CHIMERIX INC. - More news...
- Rubric Capital Management Sends Letter to Chimerix Board of Directors
- Thinking about buying stock in Confluent, Chimerix, Peabody Energy, Taysha Gene Therapies, or Transocean?
- Thinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen?
- Thinking about buying stock in Chimerix, AT&T, Canada Goose, Kodiak Sciences, or Torm?
- Thinking about buying stock in Sundial Growers, Veru, Chimerix, Vroom, or Rivian Automotive?
- Chimerix, Inc. - CMRX Stock Chart Technical Analysis for 01-08-2021
- Chimerix, Inc. - CMRX Stock Chart Technical Analysis for 12-03-2019
- Chimerix, Inc - CMRX Stock Chart Technical Analysis for 11-07-19
- Chimerix, Inc. - CMRX Stock Chart Technical Analysis for 10-25-2019
- Chimerix, Inc. - CMRX Stock Chart Technical Analysis for 05-14-2019
- Chimerix, Inc. - CMRX Stock Chart Technical Analysis for 04-09-2019
- Chimerix, Inc. to Host Earnings Call
- Investor Network: Chimerix, Inc. to Host Earnings Call
- Investor Network: Chimerix, Inc. to Host Earnings Call
- Chimerix
- Chimerix Announces Preliminary Data from Ongoing Phase 1 Dose Escalation Study of Intravenous Brincidofovir in Healthy Subjects
- Chimerix Appoints Randall Lanier, PhD as Chief Science Officer, and Roy W. Ware, PhD, MBA as Chief Manufacturing and Technology Officer
- Chimerix to Present at the 35th Annual J.P. Morgan Healthcare Conference
- Chimerix Presents Data from a Preclinical Study of Intravenous Brincidofovir at AAPS
- Chimerix to Present at Upcoming Investor Conferences
- Chimerix Announces Third Quarter 2016 Financial Results
- Chimerix to Announce Third Quarter 2016 Financial Results on November 7, 2016
- Chimerix Announces Presentation at IDWeek™ of Detailed 24-Week Results from AdVise Trial of Brincidofovir for the Treatment of Adenovirus Infection in Allogeneic Hematopoietic Cell Transplant Recipients